| Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection VVA Mallajosyula, M Citron, F Ferrara, X Lu, C Callahan, GJ Heidecker, ... Proceedings of the National Academy of Sciences 111 (25), E2514-E2523, 2014 | 200 | 2014 |
| Pseudotype neutralization assays: from laboratory bench to data analysis F Ferrara, N Temperton Methods and protocols 1 (1), 8, 2018 | 121 | 2018 |
| Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses In Vitro SE Smith, MS Gibson, RS Wash, F Ferrara, E Wright, N Temperton, ... Journal of virology 87 (23), 12957-12966, 2013 | 119 | 2013 |
| Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods A Vrdoljak, EA Allen, F Ferrara, NJ Temperton, AM Crean, AC Moore Journal of controlled release 225, 192-204, 2016 | 106 | 2016 |
| Pseudotype-based neutralization assays for influenza: a systematic analysis GW Carnell, F Ferrara, K Grehan, CP Thompson, NJ Temperton Frontiers in immunology 6, 140476, 2015 | 95 | 2015 |
| An optimised method for the production of MERS-CoV spike expressing viral pseudotypes K Grehan, F Ferrara, N Temperton MethodsX 2, 379-384, 2015 | 89 | 2015 |
| Production of lentiviral vectors using suspension cells grown in serum-free media M Bauler, JK Roberts, CC Wu, B Fan, F Ferrara, BH Yip, S Diao, YI Kim, ... Molecular Therapy-Methods & Clinical Development 17, 58-68, 2020 | 86 | 2020 |
| The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes F Ferrara, E Molesti, E Böttcher-Friebertshäuser, G Cattoli, D Corti, ... Journal of molecular and genetic medicine: an international journal of …, 2013 | 53 | 2013 |
| Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype VVA Mallajosyula, M Citron, F Ferrara, NJ Temperton, X Liang, JA Flynn, ... Frontiers in immunology 6, 329, 2015 | 44 | 2015 |
| Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses WH Mahallawi, AV Kasbekar, MS McCormick, K Hoschler, N Temperton, ... Journal of Virology 87 (10), 5331-5339, 2013 | 33 | 2013 |
| The use of equine influenza pseudotypes for serological screening S Scott, E Molesti, N Temperton, F Ferrara, E Böttcher-Friebertshäuser, ... Journal of molecular and genetic medicine: an international journal of …, 2012 | 30 | 2012 |
| An optimized method for the production using PEI, titration and neutralization of SARS-CoV spike luciferase pseudotypes G Carnell, K Grehan, F Ferrara, E Molesti, N Temperton Bio-protocol 7 (16), e2514-e2514, 2017 | 27 | 2017 |
| Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses CTO Benfield, SE Smith, E Wright, RS Wash, F Ferrara, NJ Temperton, ... Journal of General Virology 96 (5), 991-1005, 2015 | 27 | 2015 |
| The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses E Molesti, G Cattoli, F Ferrara, E Böttcher-Friebertshäuser, C Terregino, ... Journal of molecular and genetic medicine: an international journal of …, 2013 | 26 | 2013 |
| Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection MS Ahmed, LC Jacques, W Mahallawi, F Ferrara, N Temperton, N Upile, ... Antiviral research 114, 106-112, 2015 | 25 | 2015 |
| Optimizing lentiviral vector transduction of hematopoietic stem cells for gene therapy Y Jang, YS Kim, MM Wielgosz, F Ferrara, Z Ma, J Condori, LE Palmer, ... Gene therapy 27 (12), 545-556, 2020 | 23 | 2020 |
| Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by modified vaccinia Ankara-vectored influenza vaccines J Mullin, MS Ahmed, R Sharma, N Upile, H Beer, P Achar, S Puksuriwong, ... Vaccine 34 (14), 1688-1695, 2016 | 22 | 2016 |
| Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza A virus challenge CM Tully, S Chinnakannan, CE Mullarkey, M Ulaszewska, F Ferrara, ... The Journal of Immunology 199 (4), 1333-1341, 2017 | 20 | 2017 |
| Next generation vaccines for infectious diseases GA Sautto, GA Kirchenbaum, RA Diotti, E Criscuolo, F Ferrara Journal of Immunology Research 2019, 2019 | 19 | 2019 |
| Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation K Lacek, RA Urbanowicz, F Troise, C De Lorenzo, V Severino, A Di Maro, ... Journal of Biological Chemistry 289 (50), 35015-35028, 2014 | 18 | 2014 |
Nigel TempertonProfessor of Molecular VirologyBestätigte E-Mail-Adresse bei kent.ac.uk
